Evidence map›Paper›PMID 41066482›Full record

ArticlePLoS neglected tropical diseases2025

Leveraging paired serology to estimate the incidence of typhoidal Salmonella infection in the STRATAA study.

Jo Walker, Paula Russell, Leanne Kermack, Tan Trinh Van, Tran Vu Thieu Nga, Elli Mylona, Susana Camara, Young Chan Kim, Sonu Shrestha, Arne Gehlhaar and 18 more

Erratum issuedAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Estimating enteric fever seroincidence in Bangladesh using rapid serosurveys.medRxiv : the preprint server for health sciences · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors.

Jo WalkerDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America.ORCID https://orcid.org/0000-0001-6130-8189
Paula RussellCambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
Leanne KermackCambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
Tan Trinh VanThe Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Tran Vu Thieu NgaThe Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Elli MylonaCambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
Susana CamaraOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
Young Chan KimInternational Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Sonu ShresthaInternational Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Arne GehlhaarInternational Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Josefin Bartholdson ScottCambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
Farhana KhanamOxford University Clinical Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal.
Mila ShakyaPatan Academy of Health Sciences, Patan Hospital, Lalitpur, Nepal.
Deus ThindwaCollege of Medicine, University of Malawi, Blantyre, Malawi.
Melita A GordonCollege of Medicine, University of Malawi, Blantyre, Malawi.
Buddha BasnyatOxford University Clinical Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal.
John D ClemensInternational Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Firdausi QadriInternational Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Robert S HeydermanMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Christiane DolecekNIHR Oxford Biomedical Research Centre, Oxford, United Kingdom.
Susan TonksOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
Thomas C DartonClinical Infection Research Group, School of Medicine & Population Health, University of Sheffield, Sheffield, United Kingdom.
Andrew J PollardOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
Stephen BakerCambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
James E MeiringMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Merryn VoyseyOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
Virginia E PitzerDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America.
and the STRATAA Study Group

Funding

Gates Foundation INV-030857Wellcome Trust
6 · The paper itself

Abstract

Serologic surveillance of at-risk populations can be used to directly estimate the incidence of typhoidal Salmonella infection across a variety of settings, including those without access to facility-based blood-culture surveillance. We collected paired blood samples approximately three months apart from an age-stratified random sample of healthy children and adults in Bangladesh, Malawi, and Nepal as part of the Strategic Typhoid Alliance Across Asia and Africa (STRATAA) study. We used a multiplex bead assay to measure the concentration of IgG antibodies against seven Salmonella typhi/paratyphi antigens (CdtB, FliC, HlyE, LPSO2, LPSO9, Vi, and YncE) in each sample and identified recently infected participants by fitting a regression mixture model to the change in IgG concentration between participants' samples. We estimated the seroincidence of infection in a Bayesian framework for each study site, age group, and antigen target. Finally, we compared the seroincidence estimates with crude and adjusted estimates of clinical incidence based on blood-culture surveillance. Seroincidence estimates were significantly higher than enteric fever incidence across all study sites, age groups, and antigen targets, even after adjusting for underreporting (median ratio: 24.2, interquartile range: 11.4-58.9). Seroincidence consistently peaked in the 0-4-year age group and declined moderately between children and adults (33% to 58% decline in HlyE seroincidence between the 5-9 and 30 + year old age groups), while enteric fever incidence peaked in older children and fell sharply in adults (71% to 95% decline in adjusted clinical incidence). Seroincidence estimates based on the FliC, YncE, and HlyE antigens individually had the strongest correlation with observed enteric fever incidence across age groups and study sites (r = 0.72, 0.69, and 0.63, respectively). These findings suggest that in endemic settings, both children and adults are frequently infected by typhoidal Salmonella serotypes, although only a fraction of these infections present as clinically identifiable enteric fever cases.

Indexed as

Antibodies, BacterialSalmonella typhiTyphoid FeverAdolescentAdultAntigens, BacterialBangladeshBayes TheoremChildChild, PreschoolFemaleHumansImmunoglobulin GIncidenceInfantMalawiAntibodies, BacterialAntigens, BacterialImmunoglobulin G

Identifiers

PMID41066482
PMCPMC12527133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.